WuXi Biologics (Drug Product Plant in Leverkusen, Germany) Overview
- Status
-
Acquired/Merged
- Employees
-
150
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
2
WuXi Biologics (Drug Product Plant in Leverkusen, Germany) General Information
Description
Pharmaceutical products manufacturing plant based in Leverkusen, Germany. The asset offers filling and freeze-drying of the blood-coagulation medications.
Contact Information
Corporate Office
- North Rhine-Westphalia
- Leverkusen
- Germany
Corporate Office
- North Rhine-Westphalia
- Leverkusen
- Germany
WuXi Biologics (Drug Product Plant in Leverkusen, Germany) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
WuXi Biologics (Drug Product Plant in Leverkusen, Germany) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
WuXi Biologics (Drug Product Plant in Leverkusen, Germany) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
WuXi Biologics (Drug Product Plant in Leverkusen, Germany) FAQs
-
Where is WuXi Biologics (Drug Product Plant in Leverkusen, Germany) headquartered?
WuXi Biologics (Drug Product Plant in Leverkusen, Germany) is headquartered in Leverkusen, Germany.
-
What is the size of WuXi Biologics (Drug Product Plant in Leverkusen, Germany)?
WuXi Biologics (Drug Product Plant in Leverkusen, Germany) has 150 total employees.
-
What industry is WuXi Biologics (Drug Product Plant in Leverkusen, Germany) in?
WuXi Biologics (Drug Product Plant in Leverkusen, Germany)’s primary industry is Buildings and Property.
-
Is WuXi Biologics (Drug Product Plant in Leverkusen, Germany) a private or public company?
WuXi Biologics (Drug Product Plant in Leverkusen, Germany) is a Private company.
-
What is the current valuation of WuXi Biologics (Drug Product Plant in Leverkusen, Germany)?
The current valuation of WuXi Biologics (Drug Product Plant in Leverkusen, Germany) is .
-
What is WuXi Biologics (Drug Product Plant in Leverkusen, Germany)’s current revenue?
The current revenue for WuXi Biologics (Drug Product Plant in Leverkusen, Germany) is .
-
Who are WuXi Biologics (Drug Product Plant in Leverkusen, Germany)’s investors?
Bayer and WuXi Biologics have invested in WuXi Biologics (Drug Product Plant in Leverkusen, Germany).
-
When was WuXi Biologics (Drug Product Plant in Leverkusen, Germany) acquired?
WuXi Biologics (Drug Product Plant in Leverkusen, Germany) was acquired on 30-Jun-2025.
-
Who acquired WuXi Biologics (Drug Product Plant in Leverkusen, Germany)?
WuXi Biologics (Drug Product Plant in Leverkusen, Germany) was acquired by Terumo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
